Your Online Resource for BioProcess Technology
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 
Friday, July 21, 2017  |  Volume 9 / Number 15  |  A Production of the BioProcessing Journal
ISBioTech 5th Fall Meeting
Career Development
Mass Spectrometry
September 19–22, 2017
Boston, Massachusetts USA
American Chemical Society
254th National Meeting
August 20-24, 2017
Washington, DC USA
Phacilitate Cell & Gene Therapy Europe
September 19–21, 2017
Berlin, Germany
XXV Anniversary Congress
October 17–20, 2017
Berlin, Germany
ISBioTech 8th Spring Meeting
Fan Mail
A Window To Being A Scientist
By Debbie Letham, PhD, Charles River Laboratories
Products & Services
New Portfolio for Next Generation Sequencing
Norgen Biotek Corp. recently launched a new portfolio of product and service solutions for next-generation sequencing (NGS) applications.

First, the new Small RNA Library Prep Kit consists of all the reagents and components required to generate small RNA libraries for NGS use on an Illumina platform, and has been optimized for low input RNA (0.5–1 ng). The simple and rapid workflow allows for the library to be prepared in less than 5 hours, with no gel purification required for selected types of samples. Norgen has also launched complementary products for small RNA library construction including NGS-compatible cel-miR-39 spike-in as well as the NGS Library Quantification Kit (for small RNA-seq).
product and service solutions for Next Generation Sequencing (NGS) applications

In addition, Norgen offers a wide range of NGS services including isolation, library preparation, sequencing, and bioinformatics. Norgen's state-of-the-art facility employs multiple Illumina sequencing platforms including MiSeq and NextSeq 500, allowing a full sequencing menu including small RNA-seq, RNA-seq, 16S Metagenomics, targeted (DNA/RNA) sequencing, exome sequencing, and whole genome sequencing. For more information, please visit

New Test Methods for Therapeutic Antibodies
automate the detailed analysis of the antibody's structur
Protea Biosciences Group, Inc. ("Protea") has integrated its therapeutic antibody analytical methods with new software developed by its partner, Protein Metrics, to automate the detailed analysis of the antibody's structure.

Protea's new methods can identify therapeutic antibody deviations and impurities, in the form of host cell proteins, that may occur as part of the recombinant protein production process. Peptide maps of therapeutic antibodies containing post-translational modifications, or the subtle changes of protein structure that occur after synthesis, can now be generated simultaneously while also determining the amount of other impurities present, at extremely low levels. For more information, please visit
New ADA Solution for Immunogenicity Market
Gyros Protein Technologies AB has launched a new version of its anti-drug antibody (ADA) solution for the immunogenicity market. Immunogenicity testing is a regulatory requirement as part of the safety assessment of biotherapeutic submissions. ADA immunoassays for biotherapeutics are complex and require lengthy protocols to maximize drug tolerance, minimize drug interference, and establish equilibrium, such as overnight incubations and acid sample pre-treatment.
Gyrolab™ ADA solution

Gyrolab™ ADA solution provides a nanoliter-scale method for automated acid pre-treatment in a Gyrolab Mixing CD with 96 microstructures. This flexible solution can be also used without acid dissociation. Gyrolab ADA solution enables customers to automatically run drug-tolerant ADA assays with small volumes of patient samples and reagents, reducing hands-on time and shortening run times. The Gyrolab ADA protocol and dedicated analysis software, designed for 21 CFR Part 11 compliance, streamlines workflows from assay development through to screening and confirmation. For more information, please visit

Career Development
Cell Culture-Based Viral Vaccines Course
Second Edition
September 19–22, 2017
Animal Cell Technology Course
Seventh Edition
September 24–28, 2017
Llafranc, Costa Brava, Spain
13th Conference on Protein Expression in Animal Cells
September 24–28, 2017
Valencia, Spain
BPJ Publishing
BioProcessing Journal Open Access
Techno-Blast Masthead
Cultured melanoma cells.
Advertising: Request a media kit!
Did a colleague forward this to you? Subscribe here. While we'd hate to see you go, you can unsubscribe instantly.